Comparative Study
doi: 10.1128/AAC.10.4.773.
Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin
- PMID: 984811
- PMCID: PMC429829
- DOI: 10.1128/AAC.10.4.773
Item in Clipboard
Comparative Study
Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin
Antimicrob Agents Chemother.
1976 Oct.
Abstract
The macrolide antibiotics josamycin and rosamicin were compared in vitro with erythromycin for activity against Staphylococcus aureus, S. epidermidis, and enterococci and with clindamycin for activity against a variety of anaerobic organisms. Rosamicin and erythromycin were similar in activity and superior to josamycin against aerobic cocci. Most isolates of S. aureus (96%), S. epidermidis (79%), and the enterococci (87%) were inhibited by 1.56 mug of either of the new macrolide compounds per ml. Clindamycin was the most active compound against the anaerobic organisms.
Similar articles
-
In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.Antimicrob Agents Chemother. 1976 Jul;10(1):188-90. doi: 10.1128/AAC.10.1.188. Antimicrob Agents Chemother. 1976. PMID: 984752 Free PMC article.
-
In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.Antimicrob Agents Chemother. 1976 Jun;9(6):988-93. doi: 10.1128/AAC.9.6.988. Antimicrob Agents Chemother. 1976. PMID: 7189 Free PMC article.
-
In vitro activity and clinical efficacy of clindamycin in the treatment of infections due to anaerobic bacteria.J Infect Dis. 1977 Mar;135 Suppl:S49-53. doi: 10.1093/infdis/135.supplement.s49. J Infect Dis. 1977. PMID: 850091
-
In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae.Antimicrob Agents Chemother. 1979 Feb;15(2):243-5. doi: 10.1128/AAC.15.2.243. Antimicrob Agents Chemother. 1979. PMID: 106776 Free PMC article.
-
The susceptibility of anaerobic bacteria to rosamicin, erythromycin and clindamycin and factors affecting the activity of rosamicin.J Antimicrob Chemother. 1979 Jan;5(1):61-6. doi: 10.1093/jac/5.1.61. J Antimicrob Chemother. 1979. PMID: 33142 No abstract available.
Cited by
-
Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).Clin Pharmacokinet. 1989 May;16(5):261-82. doi: 10.2165/00003088-198916050-00001. Clin Pharmacokinet. 1989. PMID: 2663300 Review. No abstract available.
-
In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.Antimicrob Agents Chemother. 1978 Aug;14(2):274-6. doi: 10.1128/AAC.14.2.274. Antimicrob Agents Chemother. 1978. PMID: 697353 Free PMC article.
-
In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin.Antimicrob Agents Chemother. 1978 Sep;14(3):493-4. doi: 10.1128/AAC.14.3.493. Antimicrob Agents Chemother. 1978. PMID: 708027 Free PMC article.
-
In vitro susceptibility of Ureaplasma urealyticum to rosaramicin.Antimicrob Agents Chemother. 1979 Jul;16(1):106-8. doi: 10.1128/AAC.16.1.106. Antimicrob Agents Chemother. 1979. PMID: 475368 Free PMC article.
-
Quantitative nasal cultures from carriers of Staphylococcus aureus: effects of oral therapy with erythromycin, rosamicin, and placebo.Antimicrob Agents Chemother. 1979 Mar;15(3):379-83. doi: 10.1128/AAC.15.3.379. Antimicrob Agents Chemother. 1979. PMID: 464564 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
